XBiotech Inc (XBIT)
6.83
+0.21
(+3.17%)
USD |
NASDAQ |
Nov 22, 16:00
6.88
+0.05
(+0.73%)
After-Hours: 20:00
XBiotech Shareholders Equity (Quarterly): 192.12M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 192.12M |
June 30, 2024 | 196.70M |
March 31, 2024 | 209.28M |
December 31, 2023 | 218.85M |
September 30, 2023 | 222.66M |
June 30, 2023 | 229.06M |
March 31, 2023 | 236.90M |
December 31, 2022 | 240.40M |
September 30, 2022 | 244.81M |
June 30, 2022 | 255.80M |
March 31, 2022 | 265.56M |
December 31, 2021 | 269.38M |
September 30, 2021 | 274.16M |
June 30, 2021 | 348.56M |
March 31, 2021 | 352.10M |
December 31, 2020 | 348.64M |
September 30, 2020 | 346.14M |
June 30, 2020 | 343.57M |
March 31, 2020 | 347.08M |
December 31, 2019 | 755.63M |
September 30, 2019 | 64.62M |
Date | Value |
---|---|
June 30, 2019 | 69.41M |
March 31, 2019 | 36.98M |
December 31, 2018 | 41.40M |
September 30, 2018 | 46.94M |
June 30, 2018 | 51.52M |
March 31, 2018 | 56.41M |
December 31, 2017 | 60.16M |
September 30, 2017 | 67.15M |
June 30, 2017 | 73.16M |
March 31, 2017 | 82.27M |
December 31, 2016 | 59.06M |
September 30, 2016 | 71.63M |
June 30, 2016 | 82.80M |
March 31, 2016 | 94.68M |
December 31, 2015 | 103.05M |
September 30, 2015 | 114.08M |
June 30, 2015 | 123.98M |
March 31, 2015 | 54.86M |
December 31, 2014 | 59.03M |
September 30, 2014 | 17.22M |
December 31, 2013 | 10.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
192.12M
Minimum
Sep 2024
755.63M
Maximum
Dec 2019
294.87M
Average
260.68M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 209.85M |
Total Liabilities (Quarterly) | 17.74M |